Jin Medical International annual ebitda
2021
2022
2023
2024
2025
Jin Medical International EBITDA Growth & History (ZJYL)
Jin Medical International's calculated EBITDA was $851,585 for fiscal 2025.
View full Jin Medical International company overviewJin Medical International annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-09-30 | $851,585 | −$3.0M | −78.03% |
| 2024 | 2024-09-30 | $3.9M | $783,407 | +25.33% |
| 2023 | 2023-09-30 | $3.1M | $600,043 | +24.07% |
| 2022 | 2022-09-30 | $2.5M | −$484,989 | −16.29% |
| 2021 | 2021-09-30 | $3.0M | — | — |
Jin Medical International quarterly ebitda
No reported data
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|
Jin Medical International ebitda trends
Across the available reported history, Jin Medical International's ebitda decreased from $3.9M to $851,585, a change of −$3.0M.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Jin Medical International filings at SEC.gov ↗